Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
The Journal of Biological Chemistry|April 19, 1996
Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db miceB Zhang, M P Graziano, T W Doebber, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 22, 2008
The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)Geoffrey B Varty, Sherry X Lu, Cynthia A Morgan, et al.
Frontiers in Cardiovascular Medicine|November 28, 2022
Activin A directly impairs human cardiomyocyte contractile function indicating a potential role in heart failure developmentScott MacDonnell, Jake Megna, Qin Ruan, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2012
Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain L-2-hydroxy acid oxidaseDinesh A Barawkar, Anish Bandyopadhyay, Anil Deshpande, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 21, 2019
Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective studyE Gobbini, R Chiari, P Pizzutillo, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2011
Discovery of a potent and selective small molecule hGPR91 antagonistDebnath Bhuniya, Dhananjay Umrani, Bhavesh Dave, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2005
The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)Margarita Garcia-Calvo, JeanMarie Lisnock, Herbert G Bull, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Potent and Selective Inhibitors of Long Chain l-2-Hydroxy Acid Oxidase Reduced Blood Pressure in DOCA Salt-Treated RatsDinesh A Barawkar, Ashwin Meru, Anish Bandyopadhyay, et al.
Pageof 14